Carl F. Nathan
Direktor/Vorstandsmitglied bei Tres Cantos Open Lab Foundation
Ursprung des Netzwerks ersten Grades von Carl F. Nathan
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Tres Cantos Open Lab Foundation
 Tres Cantos Open Lab Foundation Miscellaneous Commercial ServicesCommercial Services Tres Cantos Open Lab Foundation provides research facilities for charity. The non-profit company is based in Guildford, UK.
7
| Non-Profit Organization | Miscellaneous Commercial Services | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Carl F. Nathan
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chief Executive Officer | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman | |
| Brown University | College/University | Undergraduate Degree | |
| Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree | |
| ABBOTT INDIA LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Hudson-Douglas Ltd. | President | ||
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member | |
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor | |
| AN2 THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Knoll Pharmaceutical Co. | Chief Tech/Sci/R&D Officer | ||
| University of Cambridge | College/University | Graduate Degree | |
| Imperial College London | College/University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| Vereinigtes Königreich | 3 |
| Indien | 2 |
| Deutschland | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 5 |
| Finance | 2 |
Operativ
| Director/Board Member | 11 |
| Chief Tech/Sci/R&D Officer | 4 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| President | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Carl F. Nathan
- Unternehmensverbindungen
